BioCentury
ARTICLE | Company News

Chattem Inc., sanofi-aventis deal

January 4, 2010 8:00 AM UTC

sanofi-aventis will acquire consumer healthcare company Chattem for $93.50 per share, or about $1.9 billion in cash. The price is a 34% premium to Chattem's close of $69.98 on Dec. 18, 2009, the last ...